Clinical Trials Directory

Trials / Completed

CompletedNCT03970759

Meta-analysis of Stannous Fluoride and the Effects on Gingival Health

A Review of Meta-Analyses on Bioavailable Stannous Fluoride Dentifrices: Effects on Gingival Health

Status
Completed
Phase
Study type
Observational
Enrollment
2,890 (actual)
Sponsor
Procter and Gamble · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this 18 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices when used up to 3 months on gingivitis relative to a positive or negative control dentifrice.

Conditions

Interventions

TypeNameDescription
DRUGStannous Fluoride DentifriceExperimental stannous fluoride (0.454%) dentifrice
DRUGPositive control dentifricePositive control dentifrice containing (0.3%) triclosan.
DRUGNegative control dentifriceNegative control dentifrice containing either sodium fluoride (0.243%) or sodium monofluorophosphate (0.76%)

Timeline

Start date
2018-01-08
Primary completion
2018-11-30
Completion
2018-11-30
First posted
2019-06-03
Last updated
2019-06-17

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03970759. Inclusion in this directory is not an endorsement.